Virios Therapeutics Inc expected to post a loss of 7 cents a share - Earnings Preview

Dogwood Therapeutics

08/08/2023 22:21

* Virios Therapeutics Inc  VIRI.OQ   VIRI.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 10. 
    * 
    * ​Refinitiv's mean analyst estimate for Virios Therapeutics
Inc
is for a loss of 7 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Virios
Therapeutics Inc is $3.5​, above​ its last closing price
of $1.69. ​​​

This summary was machine generated August 8 at 21:21 GMT.  All
figures in US dollars  unless otherwise stated